"We’re the leading mental health provider in the region, and we have integrated Pharmacy, Primary Care, Aesthetics, and Research divisions all in the same location. Everything you need for top-quality care is in one convenient place, from counseling and therapy to vaccinations and TMS, we do it all. We’re always taking new patients with every kind of health insurance, and we’ve had the tremendous opportunity to partner with many thousands of patients in their care. Our Services Include: Behavioral Health Neuromuscular Specialty Care Counseling Services Primary Care Research On-Site Pharmacy Aesthetics Division"

During the past decade, Alivation Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alivation Research" #1 sponsor was "Abbott Nutrition" with 2 trials, followed by "Akili Interactive Labs, Inc." with 2 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Alivation Research" are "Attention Deficit Hyperactivity Disorder" (2 trials), "Depressive Disorder, Major" (2 trials), "Major Depressive Disorder" (2 trials), "Acute Treatment of Migraine" (1 trials) and "Gastro-Intestinal Tolerance" (1 trials). Many other conditions were trialed in "Alivation Research" in a lesser frequency.

Most popular intervention types in "Alivation Research" are "Drug" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fluoxetine" (2 trials), "Rapastinel" (2 trials), "AKL-T01" (1 trials) and "Control Infant Formula" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alivation Research" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Alivation Research". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Alivation Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alivation Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".